Meditrial SrL
9
3
4
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 9 trials
100.0%
+13.5% vs industry average
11%
1 trials in Phase 3/4
0%
0 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
European Study of the BrioVAD Heart Pump for Advanced Heart Failure
Role: collaborator
AHEAD: European Feasibility Study of the Cardiovalve Transfemoral Mitral Valve System
Role: collaborator
International Multicenter Study of the Navitor/Navitor Vision Transcatheter Aortic Valve Platform
Role: collaborator
KiteLock 4% EDTA Lock Solution for the Prevention of Occlusions in Children With Intestinal Failure
Role: collaborator
Rarecells Molecular Biomarkers for Early Detection of Lung Cancer
Role: collaborator
Devintec OR-AT0222 Oral Gel for the Treatment of Canker Sores: A Double Blind, Randomized, Placebo Controlled Clinical Investigation
Role: collaborator
Optical Coherence Tomography Assessment of Gender diVersity In Primary Angioplasty. The OCTAVIA Trial
Role: collaborator
Hybrid Staged Operating Room and Interventional Catheter Ablation for Atrial Fibrillation
Role: collaborator
Myovista iECG for Detecting Ischemic Heart Disease: Comparison With Computed Tomography Coronary Angiography
Role: collaborator
All 9 trials loaded